Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey

키워드

참고문헌 (17)

1. Myers JD, "Occlusive hepatic venous catheterization in the study of the normal liver, cirrhosis of the liver and noncirrhotic portal hypertension", Circulation, 13, pp.368~380 (1956)
2. Thalheimer U, "Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients", Dig Liver Dis, 37, pp.601~608 (2005)
3. Viallet A, "Comparison of free portal venous pressure and wedged hepatic venous pressure in patients with cirrhosis of the liver", Gastroenterology, 59, pp.372~375 (1970)
4. Ripoll C, "Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis", Gastroenterology, 133, pp.481~488 (2007)
5. Sandrin L, "Transient elastography : a new noninvasive method for assessment of hepatic fibrosis", Ultrasound Med Biol, 29, pp.1705~1713 (2003)
6. de Franchis R, "Expanding consensus in portal hypertension : report of the Baveno VI consensus workshop : stratifying risk and individualizing care for portal hypertension", J Hepatol, 63, pp.743~752 (2015)
7. de Franchis R, "Baveno VII-renewing consensus in portal hypertension", J Hepatol, 76, pp.959~974 (2022)
8. Yu Jun Wong, "Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients", Clinical and Molecular Hepatology, 29(1), pp.135~145 (2023), 대한간학회
9. Abraldes JG, "Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis : the"ANTICIPATE"study", Hepatology, 64, pp.2173~2184 (2016)
10. Pons M, "Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease", Am J Gastroenterol, 116, pp.723~732 (2021)
11. Semmler G, "Non-invasive tests for clinically significant portal hypertension after HCV cure", J Hepatol, 77, pp.1573~1585 (2022)
12. Dajti E, "A combined Baveno VII and spleen stiffness algorithm to improve the noninvasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease", Am J Gastroenterol, 117, pp.1825~1833 (2022)
13. Beom Kyung Kim, "The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?", Clinical and Molecular Hepatology, 27(1), pp.91~93 (2021), 대한간학회[DOI]
14. Pons M, "Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease", Dig Liver Dis, 48, pp.1214~1219 (2016)
15. Hagström H, "Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease", J Hepatol, 73, pp.1023~1029 (2020)
16. Kim HY, "Noninvasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices", J Hepatol, 70, pp.412~422 (2019)
17. Marasco G, "Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients", Hepatol Int, 14, pp.850~857 (2020)

관련 논문AI추천